Seroprevalence of measles antibody in the US population, 1999-2004
- PMID: 18008224
- DOI: 10.1086/522866
Seroprevalence of measles antibody in the US population, 1999-2004
Abstract
Background: Endemic measles transmission was declared eliminated in the United States in 2000. To ensure that elimination can be maintained, high population immunity must be sustained and monitored. Testing for measles antibody was included in the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey, conducted during 1999-2004.
Methods: A measles-specific immunoassay was used to measure the seroprevalence of measles antibody in NHANES participants 6-49 years of age. For analysis, participants were grouped by birth cohort.
Results: During 1999-2004, the rate of measles seropositivity in the population overall was 95.9% (95% confidence interval [CI], 95.1%-96.5%). The highest seroprevalence of measles antibody was in non-Hispanic blacks (98.6% [95% CI, 98.0%-99.1%]). Those born during 1967-1976 had significantly lower levels of measles antibody (92.4% [95% CI, 90.8%-93.9%]) than did the other birth cohorts. Independent predictors of measles seropositivity in the 1967-1976 birth cohort were non-Hispanic/black race/ethnicity, more than a high school education, having health insurance, and birth outside the United States.
Conclusions: Measles seropositivity was uniformly high in the US population during 1999-2004. Nearly all population subgroups had evidence of measles seropositivity levels greater than the estimated threshold necessary to sustain measles elimination. Non-Hispanic whites and Mexican Americans born during 1967-1976 had the lowest measles seropositivity levels and represent populations that might be at increased risk for measles disease if the virus were reintroduced into the United States.
Comment in
-
Building an immunity fence against measles.J Infect Dis. 2007 Nov 15;196(10):1433-5. doi: 10.1086/522868. Epub 2007 Oct 31. J Infect Dis. 2007. PMID: 18008219 No abstract available.
Similar articles
-
National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.MedGenMed. 2001 Jan 24:E5. MedGenMed. 2001. PMID: 11320344
-
Population immunity to measles in the United States, 1999.J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. doi: 10.1086/377713. J Infect Dis. 2004. PMID: 15106096 Review.
-
Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010.Vaccine. 2012 May 14;30(23):3355-9. doi: 10.1016/j.vaccine.2012.03.073. Epub 2012 Apr 5. Vaccine. 2012. PMID: 22484294
-
Prevalence of syphilis seroreactivity in the United States: data from the National Health and Nutrition Examination Surveys (NHANES) 2001-2004.Sex Transm Dis. 2008 May;35(5):507-11. doi: 10.1097/OLQ.0b013e3181644bae. Sex Transm Dis. 2008. PMID: 18356772
-
Defining and assessing measles elimination goals.J Infect Dis. 2004 May 1;189 Suppl 1:S23-6. doi: 10.1086/381556. J Infect Dis. 2004. PMID: 15106085 Review.
Cited by
-
Loss of humeral immunity in childhood cancer survivors not having undergone hematopoietic stem cell transplantation.Cancer Rep (Hoboken). 2023 Dec;6(12):e1907. doi: 10.1002/cnr2.1907. Epub 2023 Oct 22. Cancer Rep (Hoboken). 2023. PMID: 37867406 Free PMC article.
-
Impact of clinico-biochemical and inflammatory biomarkers on the immunogenicity and efficacy of SARS-CoV-2 adenoviral vaccine: a longitudinal study.J Circ Biomark. 2023 Sep 20;12:34-43. doi: 10.33393/jcb.2023.2480. eCollection 2023 Jan-Dec. J Circ Biomark. 2023. PMID: 37744159 Free PMC article.
-
Ancestry-based differences in the immune phenotype are associated with lupus activity.JCI Insight. 2023 Aug 22;8(16):e169584. doi: 10.1172/jci.insight.169584. JCI Insight. 2023. PMID: 37606045 Free PMC article.
-
U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020-February 2022.PLOS Glob Public Health. 2022 Aug 5;2(8):e0000658. doi: 10.1371/journal.pgph.0000658. PLOS Glob Public Health. 2022. PMID: 36157894 Free PMC article.
-
Shifting our stance for current COVID-19 outbreaks: A global response to an international pandemic.J Glob Health. 2021 Dec 11;11:03123. doi: 10.7189/jogh.11.03123. eCollection 2021. J Glob Health. 2021. PMID: 34956633 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical